August 18, 2010: .S. Pharma Consolidation, New Alternative to Traditional Semiconductors, Final draft of ISO 14644-9

Printer Friendly

Forward to a Friend

Share this

FEATURE ARTICLE

The Devil Is In the Details

By Bikash Chatterjee

Consolidation on a massive scale amongst the elite of the U.S. pharmaceutical industry raises questions about how to remain competitive, and profound changes to the marketplace can be seen on all fronts.

Link:

August 18, 2010